Genetic Predisposition to Solid Pediatric Cancers
Progresses over the past years have extensively improved our capacity to use genome-scale analyses—including high-density genotyping and exome and genome sequencing—to identify the genetic basis of pediatric tumors. In particular, exome sequencing has contributed to the evidence that about 10% of ch...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.590033/full |
id |
doaj-4116e4e63c6242a0830ff6251685d6c0 |
---|---|
record_format |
Article |
spelling |
doaj-4116e4e63c6242a0830ff6251685d6c02020-11-25T03:38:35ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-10-011010.3389/fonc.2020.590033590033Genetic Predisposition to Solid Pediatric CancersMario Capasso0Mario Capasso1Annalaura Montella2Matilde Tirelli3Matilde Tirelli4Teresa Maiorino5Teresa Maiorino6Sueva Cantalupo7Sueva Cantalupo8Achille Iolascon9Achille Iolascon10Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, ItalyCEINGE Biotecnologie Avanzate, Naples, ItalyCEINGE Biotecnologie Avanzate, Naples, ItalyCEINGE Biotecnologie Avanzate, Naples, ItalyEuropean School of Molecular Medicine, Università Degli Studi di Milano, Milan, ItalyDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, ItalyCEINGE Biotecnologie Avanzate, Naples, ItalyDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, ItalyCEINGE Biotecnologie Avanzate, Naples, ItalyDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, ItalyCEINGE Biotecnologie Avanzate, Naples, ItalyProgresses over the past years have extensively improved our capacity to use genome-scale analyses—including high-density genotyping and exome and genome sequencing—to identify the genetic basis of pediatric tumors. In particular, exome sequencing has contributed to the evidence that about 10% of children and adolescents with tumors have germline genetic variants associated with cancer predisposition. In this review, we provide an overview of genetic variations predisposing to solid pediatric tumors (medulloblastoma, ependymoma, astrocytoma, neuroblastoma, retinoblastoma, Wilms tumor, osteosarcoma, rhabdomyosarcoma, and Ewing sarcoma) and outline the biological processes affected by the involved mutated genes. A careful description of the genetic basis underlying a large number of syndromes associated with an increased risk of pediatric cancer is also reported. We place particular emphasis on the emerging view that interactions between germline and somatic alterations are a key determinant of cancer development. We propose future research directions, which focus on the biological function of pediatric risk alleles and on the potential links between the germline genome and somatic changes. Finally, the importance of developing new molecular diagnostic tests including all the identified risk germline mutations and of considering the genetic predisposition in screening tests and novel therapies is emphasized.https://www.frontiersin.org/articles/10.3389/fonc.2020.590033/fullgenetic predispositiongermline variantscancer predisposition genespediatric tumorscancer susceptibilitygermline-somatic interaction |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mario Capasso Mario Capasso Annalaura Montella Matilde Tirelli Matilde Tirelli Teresa Maiorino Teresa Maiorino Sueva Cantalupo Sueva Cantalupo Achille Iolascon Achille Iolascon |
spellingShingle |
Mario Capasso Mario Capasso Annalaura Montella Matilde Tirelli Matilde Tirelli Teresa Maiorino Teresa Maiorino Sueva Cantalupo Sueva Cantalupo Achille Iolascon Achille Iolascon Genetic Predisposition to Solid Pediatric Cancers Frontiers in Oncology genetic predisposition germline variants cancer predisposition genes pediatric tumors cancer susceptibility germline-somatic interaction |
author_facet |
Mario Capasso Mario Capasso Annalaura Montella Matilde Tirelli Matilde Tirelli Teresa Maiorino Teresa Maiorino Sueva Cantalupo Sueva Cantalupo Achille Iolascon Achille Iolascon |
author_sort |
Mario Capasso |
title |
Genetic Predisposition to Solid Pediatric Cancers |
title_short |
Genetic Predisposition to Solid Pediatric Cancers |
title_full |
Genetic Predisposition to Solid Pediatric Cancers |
title_fullStr |
Genetic Predisposition to Solid Pediatric Cancers |
title_full_unstemmed |
Genetic Predisposition to Solid Pediatric Cancers |
title_sort |
genetic predisposition to solid pediatric cancers |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2020-10-01 |
description |
Progresses over the past years have extensively improved our capacity to use genome-scale analyses—including high-density genotyping and exome and genome sequencing—to identify the genetic basis of pediatric tumors. In particular, exome sequencing has contributed to the evidence that about 10% of children and adolescents with tumors have germline genetic variants associated with cancer predisposition. In this review, we provide an overview of genetic variations predisposing to solid pediatric tumors (medulloblastoma, ependymoma, astrocytoma, neuroblastoma, retinoblastoma, Wilms tumor, osteosarcoma, rhabdomyosarcoma, and Ewing sarcoma) and outline the biological processes affected by the involved mutated genes. A careful description of the genetic basis underlying a large number of syndromes associated with an increased risk of pediatric cancer is also reported. We place particular emphasis on the emerging view that interactions between germline and somatic alterations are a key determinant of cancer development. We propose future research directions, which focus on the biological function of pediatric risk alleles and on the potential links between the germline genome and somatic changes. Finally, the importance of developing new molecular diagnostic tests including all the identified risk germline mutations and of considering the genetic predisposition in screening tests and novel therapies is emphasized. |
topic |
genetic predisposition germline variants cancer predisposition genes pediatric tumors cancer susceptibility germline-somatic interaction |
url |
https://www.frontiersin.org/articles/10.3389/fonc.2020.590033/full |
work_keys_str_mv |
AT mariocapasso geneticpredispositiontosolidpediatriccancers AT mariocapasso geneticpredispositiontosolidpediatriccancers AT annalauramontella geneticpredispositiontosolidpediatriccancers AT matildetirelli geneticpredispositiontosolidpediatriccancers AT matildetirelli geneticpredispositiontosolidpediatriccancers AT teresamaiorino geneticpredispositiontosolidpediatriccancers AT teresamaiorino geneticpredispositiontosolidpediatriccancers AT suevacantalupo geneticpredispositiontosolidpediatriccancers AT suevacantalupo geneticpredispositiontosolidpediatriccancers AT achilleiolascon geneticpredispositiontosolidpediatriccancers AT achilleiolascon geneticpredispositiontosolidpediatriccancers |
_version_ |
1724541633971617792 |